Certolizumab to treat hidradenitis suppurativa

Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that affects apocrine gland-bearing skin. The management of HS with biologics has expanded significantly over the past few years. Certolizumab pegol is a pegylated (polyethylene glycol) antigen-binding fragment of a recombinant h...

Descripción completa

Detalles Bibliográficos
Autores principales: Shadid, Asem, Alobaida, Saud, Binamer, Yousef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312105/
https://www.ncbi.nlm.nih.gov/pubmed/37397399
http://dx.doi.org/10.4081/dr.2022.9566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312105/
https://www.ncbi.nlm.nih.gov/pubmed/37397399
http://dx.doi.org/10.4081/dr.2022.9566

Ejemplares similares